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I N T RO DU CT I O N
The dexamethasone suppression test (DST) is the most extensive ly studied
biological test in psychiatry. Despite this, its role in the diagn ostic assessment of
psych iatric patients remains controversial. Shortcomings of th e test incl ude
limited sensi tivity (45%) and lim ited specificity (75-80%) (1). T he DST has many
proposed uses, in cluding the differentiation of endogenous from non-endoge-
nous depressions, helpi ng to decide when maintenance medications may be
withdrawn, and as a d iagnostic test fo r major depression. This paper is con-
cerned wit h the latter use only, that is, the ability of the DST to fu nction as a
useful diagnostic test for major depression .
The significance of the low se nsit ivity and specificity of the DST have been
dis cussed extensively in the psychiatric lite rature (2 ,3). When the DST is used as
a diagnostic test for major depression its sensitivit y represents the likel ihood of a
positive test given that the te sted patient has a major depression. Specificity
represents the likelihood of a negative test given that the tested pati ent does not
have a major depression . Notably, both sensitivity and specificity represent
probabilities conditional on the presence or abse nce of disease . H owever , in the
usual clinical situation, the diagnosis is unknown at the time the di agnostic test is
ordered. Indeed, if the diagnosis is known then the test should not be per-
formed . Thus neither sensit ivit y nor specificity is directl y rel evant to the inter-
pretation of the results of diagnostic tests in a clinical se tt ing. Another parame-
te r, the positive predictive value (+ PV), is of more clinical relevance.
The usual formula for +PV is:
true positives
+ PV = . . C I . .true posItIve + ra se posItIves
This formu la is difficult to apply in practice because the ' t rue' di sease status must
be known to identify true and fal se positives. Howe ver, th e +PV can be
estimated using another formula (which is actually an application of Bayes'
theorem):
Se (Pr)
+ PV = ---:-----,----.,----------:----,------:-
Se (Pr) + (I - Sp) (I - Pr)
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Se = sens itivity
Sp = specificity
Pr = pre-test probability
The + PV of th e DST represents the probability that a pat ient has major
depression , g iven that th e DST is nonsuppressin g. T h us , u nli ke sens itivity and
specificity , + PV quite closely reflects the process o f clinical j udgement faced by
th e clinician in interpreting the results of a diagnostic test such as the DST . T he
+ PV is affected by se nsit ivity, specificity and by th e pre-t est probabi lity. Pre-test
probability refers to the likelihood that a patient has the condi t ion be ing tested
for before the diagnostic test is performed. The usefulness of any di agnostic test
relates to its ability to change this probability. In an absolu te se nse , the probabil-
ity that the relevant illness is present is not cha nge d by th e d iagnost ic test.
However, a clinician's best judgement about th e co r rect diagnosis can be
cha nge d by a test result. For example, if a clinician believes that the probab ilit y
of major depression in a given patient is say, 50 % (pre-tes t probabil ity) and a
positive DST increases that probability to 90 % (in other words has a positiv e
predictive value of 90 %) then the test ha s obviously bee n very use ful as a
diagnostic te st for that patient.
The pre-test probability of maj or depression in a given pati ent is influe nced
by th e clini cal symptomatology exhibited by that patie nt. T h is parameter is
diffi cult to quantify. However, the pre-test probability is also influenced by a
number of demographic variables whi ch are easy to quantify such as age, sex,
e tc. The pre-test probability of depression in any subgroup of patie nts identified
by such a var iable (eg. females aged 40-60 yea rs) is equ ivalent to th e poi nt
prevalence of major depression in that particul ar subgroup of pat ients. Th us,
prevalence rates of major depression in subgroups of patients in a clin ica l sett ing
a llow for the estimation of pre-test probability and subsequently, the use of this
parameter in clinical deci sion making.
The relationship between predictive va lue, sens itivi ty, specificity an d pre-
test probability is of critical importance in the interpretati on of diagnost ic test
results. For example, the DST is generally regarded as a relatively specific test if
ce rta in exclusion criteria are adhered to in choosin g ca nd idates for the test. By
definition, a specific test is very likely to be negative if a patient does no t have th e
cond it ion being tested for , in this case, depression. Clinician s, th erefo re , may
assume that a positive DST is fairl y strongly indicative of depression . Howeve r ,
this is not necessarily the case ; in fact, for statistical reaso ns (which will be
di scu ssed below) a positive DST may be very sign ifica n t in so me cases and
vir tua lly insignificant in others.
As di scu ssed previously, the usefulness of a ny di agnostic test rela tes to its
ability to alter the pre-test probability. The sta t ist ica l method designed to
quanti fy this alteration in probability is the post-test probability di ffe re nce . T h is
sta tis t ic represents th e difference between the pre- an d post-test probability
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which is produced by a positive test. The post-test probability difference is
perhaps the best estimate of the contribution (in terms of probability) of a
diagnostic test to clinical judgement.
Another issue related to the interpretation of diagnostic test s is th e negative
predictive value (- PV). This parameter quantifies the probabilit y that an
individual with a negative test actually does not have th e d isea se in question .
Because the DST is an insensitive test, its negative predictive value is always very
small and negative test results can never playa major role in diagnostic decision
making. The negative predictive value of the DST will therefore no t be dis-
cussed.
Problems related to the interpretation of diagnostic data , suc h as those
discussed above, have received attention in the medical lit eratu re (4) , includ ing
the psychiatric literature (5). On some occasions, th ese principl es have been
applied formally to complex clinical problems (6,7) . However, ne ithe r empiri-
cally derived estimates of +PV nor of post-test probability di ffere nce are
generally available in the psychiatric literature. In fact , because the + PV varies
depending on the pre-test probability of depression , the + PV of th e DST is
likely to be different in different groups and in different clinical se tti ngs. Using
Bayes' theorem and estimates of sensitivity, specificity, and pre-test p robabil ity
of depression, one can calculate + PV and post-test probability d ifference.
Because pre-test probability can be easily estimated from chart reviews or
existing records, this method provides a practical way of making th ese pa rame-
ters available to clinicians in a particular setting who may use the DST . In fact ,
the use of Bayes' Theorem should enable any clinician with a ba sic kn owledge of
the patient population in his or her clinical setting to est imate th e predictive
value of the DST in a few seconds using only basic algebra. This, in turn , should
result in more sophisticated and accurate interpretation of DST results.
ESTIMATION OF PREDICTIVE VALUE OF THE DST:
As stated previously, Bayes' theorem can be written as:
Se (Pr)
+ PV = ---,-----,----,-----,------,-
Se (Pr) + (I - Sp)(I - Pr)
Where:
Se = sensitivity
Sp = specificity
Pr = pre-test probability
For any particular subgroup of psychiatric patients in a particul ar setting
the pre-test probability of depression can be est imated as th e prevale nce of
major depression in that subgroup. The necessary information ca n be easily
gathered by examining existing records of samples of patients in th at fac ility . In
some cases it may be possible to gather the necessary information from adm in is-
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trative statistical records or medical r ecords data bases. For exa m ple, if 40 % of
females admitted to a pa rticular unit have major depression , then th e pre-test
probability of major depression for fe males , as a group, is 40%. Exist ing
estimates of sensitivity and specificity from the cu rrent lite ra tu re can be used in
the formula. The post-test probability difference is calculated by subtracting the
pre-test probability fr om the +PV.
As an exa mp le of this method, we have recently estimated th e + PV and
post-test probability difference of the DST in various subgroups of pa tients
admitted to the Calgary General Hospital. Within th is paper, the example ser ves
two purposes; it generates estimates of +PV and post-test probabi lity di fference
for the DST (such est imates are generally not avai lable in the psychiat r ic
literature), and it also illustrates the method wh ereby such estimates can be
generated for different psychiatric settings using Bayes' T heorem.
METHODS
The medical records of all patients di scharged from the psychi atric inpa-
tient units at the Calgary General Hospital over a th ree month period were
reviewed. This sample consisted of 243 patients. Informat io n regard ing the
presence or absence of a number of variables r elevant to depression was
gathered. The variab les included age, sex , marital sta tus, employment sta tus,
pa st psychiatric history, family history, and the presence or absence of suicidal
ideation. The patients in the sample were divided accord ing to these var iables
into sub-groups and the proportion of patients in each group receiving a clinical
diagnosis of major depression was recorded. The prevale nce of depression in
each subgroup was taken as the pre-test probability of depression in that
subgroup. Bayes ' theorem was then used to estimate the + PV for the DST in
each group. Previously published estimates of sens itivity and specificity (1) we re
used in the calcu lat ions . Post-test probability difference was calculated by su b-
tracting the pre-test probability from the + PV .
RESULTS
The results of the chart review are presented in two stacked bar graphs,
table # 1 and table # 2 . In each graph, the bottom portions of the bar s represent
the pre-test probability of depression in the var ious ly defined clin ica l groups.
The upper portions represent the amount the DST adds to th e estimate d
probability of major depression (the post te st probability d ifference). T he to ta l
height of each bar represents the positive predictive value of the test .
Within different clinical groups, the pre-test probability of depression var ies
markedly. In this chart review, the prevalence of major depression varied fro m
3% (in males aged 20-40) to 59 % (individuals with a past hi sto ry of depression).
It ca n be seen that the post-test probability of depression is larger for clinica l
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Predictive Value of the DST
Pre & Post-Test Probability byAge & Sex
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groups with a higher pre-test probability of depression. In real ity, the post-test
probabi lity d ifference is maximal when the pre-test probabil ity is 50%. The
post-test probabi lity, consequently, tends to be larger in groups wit h h igh
pre-test proba b ility.
Generally, the test ge nerated h ighe r pred ict ive values in 40-60 yea r olds
than in 20:"'-40 year o lds. T he test generated higher predictive valu es in patie n ts
belonging to cl inical groups which are at high risk for depression ; females,
individua ls with a past h istory of depression, and individuals with a family h isto ry
of depression .
DISCUSSION
In several situat ions, na mely in patients wit h a fami ly history of depressio n
an d in patients with a past hi sto ry of depression the DST generated rea sonably
h igh +PV (6 1% and 74 % respectively) and post-test probability differences (15%
and 17% respecti vely). T his suggests that th e DST might be of some d iagnostic
va lue in these situations. O f course the DST will not be useful fo r a ll pati e n ts
with a family histo r y of depression or a past history of depression. Man y suc h
patients will be diagnosab le on clinical grounds alone; laboratory tests are not
helpfu l in this group. H owever, it is reasonable to assume th at some patients in
these subgroups will present enough diagnostic uncertainty that a d iagnostic test
could be he lpful. In the other subgroups of patients whi ch were id entified, the
pred ictive value and post-test probability di ffe re nce of the te st was so low th at it
is unlike ly that the DST could be of any be nefit to these patients.
T hese es t imates of +PV app ly only to o ne clin ical populat ion at one poi nt in
time. T he usefuln ess of the DST , as measured by + PV and post-test probabi lity
difference, might vary with time at a particu lar institu t ion and ce r ta in ly would
be expected to vary be tween institutions . However, Bayes ' Theorem can be
applied wit h min imal expense and effort to aid in the interpretation of th e DST .
The strategy described in this paper involves the collection of data releva nt
to the application of Bayes' theorem in an institution , and the subse quent use of
the theorem to enhance th e utility of the test in that institution. It should be
mentioned that Bayes' theorem could be applied to other so rts of data . For
example, prevalence es t imates from co mmuni ty based epidemiologic studies
co u ld be used to provid e es t imates of pre-test probab ility. Such an application
wo uld lead to estimate s of post-test probabi lity and post-test probability differ-
ence which were meaningful at the community level , and thus have a more
intuit ive ly meaningful interpretation . However, to the extent that selective
factors leading to admission at a particular hospital define th e nature of the
population at that institution , such estimates may not be applicable clinica lly.
In summary, re la t ive to the interpretation of some other diagn ostic tests,
the interpretation of the DST is difficult. The concepts of sensiti vity and
specificity may not provide clear guidance for clinical decision making when the
results of the test become avai lab le . Concepts such as positive predicti ve value
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and post-test probability difference can be very helpful in ca pturing the true
implications of DST results. Bayes' theorem provides a me th od of es tima t ing
these parameters. The method inv olv es gathering some data rel evan t to the
cl in ica l population in which the test is to be interpreted and some simple
algebraic ca lcu la tions .
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